Related Experiment Videos
Vectors derived from the human immunodeficiency virus, HIV-1
Edward Barker1, Vicente Planelles
1Department of Microbiology and Immunology, State University of New York, Upstate Medical University, 750 East Adams Street, Syracuse, NY, USA.
Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
Summary
Gene therapy modifies genetic material for therapeutic benefit. Lentivirus vectors are ideal for gene therapy due to their ability to infect and stably integrate genes into both dividing and non-dividing cells.
Area of Science:
- * Molecular Biology
- * Virology
- * Genetic Engineering
Background:
- * Gene therapy aims to treat diseases by modifying cellular genetic material.
- * Effective gene therapy requires sustained therapeutic gene expression without adverse effects.
- * Current research explores various somatic tissues for gene introduction.
Purpose of the Study:
- * To review available lentivirus vectors for gene therapy.
- * To discuss lentivirus vector design, applications, and safety.
- * To explore lentiviral biology relevant to vector development.
Main Methods:
- * Review of scientific literature on lentivirus vectors.
- * Analysis of lentivirus vector design principles.
- * Examination of applications in disease treatment and safety profiles.
Main Results:
- * Lentiviruses can infect and stably integrate genes into dividing and non-dividing cells.
- * Lentivirus vectors are promising candidates for gene therapy applications.
- * Key vector requirements include high titers, stable integration, and minimal immune response.
Conclusions:
- * Lentivirus vectors offer significant potential for advancing gene therapy.
- * Careful consideration of vector design and safety is crucial for clinical application.
- * Further research into lentiviral biology can optimize vector development for therapeutic use.